Article Figures & Tables
Figures
Figure 1: Selection of patient data to include in analysis of mortality associated with individual angiotensin-converting-enzyme (ACE) inhibitors among patients with congestive heart failure.
Figure 2: Unadjusted Kaplan–Meier 5-year survival curves for patients prescribed an angiotensin-converting-enzyme (ACE) inhibitor within 30 days after discharge from hospital. Data are shown for ACE inhibitors for which a significant difference in survival was observed relative to ramipril.
Figure 3: Effect of various ACE inhibitors on all-cause mortality among patients with congestive heart failure. Variables included in the models: fiscal year of admission, province of admission, length of stay, time to first ACE inhibitor prescription, specialty of treating physician, hospital characteristics (teaching v. nonteaching, volume of admissions because of congestive heart failure), comorbidities and prescriptions filled for other cardiac medications). The fixed-exposure model includes data from Quebec, Ontario and British Columbia. The time-dependent model includes data from Quebec and Ontario only. CI = confidence interval.